Search results
BioCryst Pharmaceuticals CFO buys $202k in company stock By Investing.com
Investing.com· 6 days agoThe transaction was disclosed in a filing with the Securities and Exchange Commission. This purchase...
Cold chain storage and distribution for the pharmaceutical industry
Pharmaceutical Technology via Yahoo Finance· 14 hours agoMany pharmaceutical drugs, medicines and speciality treatments are temperature-sensitive and require swift supply chains. Cold chain storage and distribution ...
EMA recommends suspension of 17-OHPC medicines in EU
Pharmaceutical Technology via Yahoo Finance· 16 hours ago“The committee is therefore recommending the suspension of the marketing authorisations for these medicines. Alternative treatment options are...
Arrowhead reports progress in asthma RNAi treatment trials By Investing.com
Investing.com· 13 hours agoArrowhead Pharmaceuticals, Inc. (NASDAQ: NASDAQ:ARWR) today shared interim clinical data from its...
Stomach paralysis risk may rise in people taking Ozempic and similar drugs
Medical Xpress· 10 hours agoPrateek Sharma, a professor of medicine at the University of Kansas School of Medicine who conducted...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 40 minutes agoTeva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) and Alvotech (NASDAQ: ALVO), today announced the availability ...
...COPD Trial Presented at ATS and Published in The New England Journal of Medicine - Regeneron ...
Benzinga· 8 hours agoNOTUS results confirm landmark data from the Phase 3 BOREAS trial and show Dupixent significantly reduced exacerbations by 34% and improved lung function, compared to placebo, in uncontrolled chronic obstructive
AstraZeneca to build $1.5bn ADCs facility in Singapore
Investment Monitor via Yahoo Finance· 17 hours agoPharmaceutical giant AstraZeneca has announced plans to invest $1.5bn in a new antibody-drug...
Tempus, Chicago's biotech darling, files to go public
Crain s Chicago Business· 4 hours agoAfter several years of speculation Tempus would go public, the AI-enabled precision-medicine startup from Eric Lefkofsky filed for an initial public offering today. The company ...
UnitedHealth's unit to launch new drug pricing model next year
Reuters via AOL· 9 hours agoThe new model, Optum Rx Clear Trend Guarantee, will provide value-based pricing of drugs per member combining the cost of these medicines from various sources such as retail ...